Cleared Traditional

K151859 - Synapse Cardiovascular

K151859 is the FDA 510(k) clearance for Synapse Cardiovascular by Fujifilm Medical Systems U.S.A, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K151859 · Fujifilm Medical Systems U.S.A, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2015
Decision
35d
Days
Class 2
Risk

K151859 is an FDA 510(k) clearance for the Synapse Cardiovascular. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical Systems U.S.A, Inc. (Stamford, US). The FDA issued a Cleared decision on August 12, 2015 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical Systems U.S.A, Inc. devices

Submission Details

510(k) Number K151859 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 2015
Decision Date August 12, 2015
Days to Decision 35 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 107d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1126
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K151859.
Stereo 3D option for Vision Applications
K152352 · GE Medical Systems SCS · Jan 2016
Ez3D Plus
K152746 · Ewoosoft Co., Ltd. · Jan 2016
CARESTREAM Vue Motion
K151774 · Carestream Health, Inc. · Sep 2015
syngo.MR Neurology, syngo.MR Oncology
K151353 · Siemens Medical Solutions USA, Inc. · Aug 2015
GenIQ
K143368 · Ge Medical Systems, LLC · Jul 2015
3D/5D Viewer
K151808 · Samsung Medison Co., Ltd. · Jul 2015